Substrate Recognition Governs Reverse Transcriptase Resistance to Diagnostic Inhibitors in RT-qPCR

Inês F. Costa, Vânia O. Fernandes, Victor D. Alves, Virgínia M. R. Pires, Joana A. Brás, Pedro Bule, Carlos M. G. A. Fontes · 2026

Read Substrate Recognition Governs Reverse Transcriptase Resistance to Diagnostic Inhibitors in RT-qPCR by Inês F. Costa, Vânia O. Fernandes, Victor D. Alves, Virgínia M. R. Pires, Joana A. Brás, Pedro Bule, Carlos M. G. A. Fontes (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13298206.txt.

Description

Diagnostic PCR fails when stray chemicals from patient samples stall the enzyme that copies RNA, and Inês F Costa with colleagues worked out why some engineered enzymes resist in a 2026 study. They tested five variants of a retroviral reverse transcriptase against eleven clinically relevant inhibitors across temperatures from 40 to 70 °C.

A recurring set of mutations, including E69K and W313F, marked the toughest enzymes, apparently by gripping the nucleic acid target more firmly. Tolerance peaked near 40 °C, where binding stayed productive; the unmodified enzyme was shut down by several inhibitors outright. The authors offer design rules for sturdier enzymes in sensitive RNA tests.

Catalog record

CREATORInês F. Costa, Vânia O. Fernandes, Victor D. Alves, Virgínia M. R. Pires, Joana A. Brás, Pedro Bule, Carlos M. G. A. Fontes
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62742
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13298206

Browse the full library · About the Tower of Babel